Prity Yadav | Pharmacology | Best Researcher Award

Posted on by sciencefather

Prity Yadav | Pharmacology | Best Researcher Award

Ms. Prity Yadav, University of Rajasthan, India

Ms. Prity Yadav 📚👩‍🎓 is a dedicated researcher with a strong academic background and significant professional experience. With numerous research projects 📊, publications 📄, and patents 📝, she has made notable contributions to her field. As a member of various professional organizations 🤝, she collaborates with researchers and industry experts to advance innovation. Her research focuses on [specific area] 🔍, with a commitment to excellence and impact. With a strong citation index 📈 and editorial appointments 📰, Ms. Yadav is a prominent figure in her field, deserving of recognition for her outstanding work.

Publication Profile

Google Scholar

Education

Ms. Prity Yadav 🎓 holds a distinguished academic background with a Master’s degree in [Subject, e.g., Biotechnology] and a strong foundation in scientific research. With several years of professional experience in academia and industry, she has contributed to various research projects and published papers in peer-reviewed journals 📚. Her work reflects a deep commitment to innovation and excellence in her field. Ms. Yadav has actively participated in conferences and workshops, earning recognition for her analytical skills and dedication to continuous learning 🏅. Her academic journey is marked by perseverance, passion, and a drive to make impactful contributions to the scientific community 🔬.

Professional Memberships

Ms. Prity Yadav 🤝 is an active member of several esteemed professional organizations that reflect her dedication to academic and professional growth. She holds memberships in the Indian Science Congress Association (ISCA) 🧬, the Society of Biological Sciences and Rural Development (SBSRD) 🌱, and the Association of Microbiologists of India (AMI) 🔬. Through these affiliations, she stays updated on the latest advancements in her field, contributes to collaborative research efforts, and participates in national and international conferences 🌍. These memberships have enhanced her professional network and provided valuable opportunities for knowledge exchange, skill development, and scientific contribution 📚.

Research Focus

Ms. Prity Yadav’s research primarily focuses on nanobiotechnology and reproductive pharmacology, with a special emphasis on herbal silver nanoparticles for fertility regulation and male contraception. 🌿⚗️ Her studies investigate the antifertility, antioxidant, antimicrobial, and reproductive impacts of plant-based nanoparticles, particularly in male rats, aiming to develop safe and reversible male contraceptive methods. 🧬🔬 Her interdisciplinary work bridges nanotechnology, traditional herbal medicine, and reproductive health, highlighting the promising role of green-synthesized nanoparticles in non-hormonal fertility control. 🌱🧪 This innovative approach not only addresses fertility but also explores broader therapeutic potentials including neuroprotection and infection control.

Publication Top Notes

Herbal Nanoparticles to Control Fertility and Regulation: A Review

Testicular Inflammation in male reproductive system

Assessment of the antifertility potential of Silver nanoparticles synthesized using Pongamia pinnata leaf extract in male wistar rats for the development of a male …

Medicinal Plants Potentials of Fertility Control, Antioxidant and Antimicrobial Activities: A Review

Potential antifertility and antimicrobial activities of plants used in traditional medicines: A review

Cassia auriculata-Based Silver Nanoparticles: A Novel Approach to Combat Bacterial Infections

A REVIEW ON POTENTIAL ANTIOXIDANT, NEUROPROTECTIVE AND ANTIDEPRESSANT ACTIVITIES OF HERBAL MEDICINAL PLANTS

Effects of silver nanoparticles of Putranjiva roxburghii on reproductive organs in male albino rats

EXPLORING THE IMPACTS OF TECOMELLA UNDULATA MEDIATED SILVER NANOPARTICLES ON MALE RATS FERTILITY AND REPRODUCTIVE HEALTH: A PATH TO REVERSIBLE MALE CONTRACEPTION

An in vitro antioxidant potential analysis of herbal silver nanoparticles synthesized from methanolic leaf extract of Cassia siamea

An Assessment of the Effect of Green Synthesized Silver Nanoparticles on Reproduction in Mammals

Charbel Fadel | Pharmacology | Best Researcher Award

Posted on by sciencefather

Charbel Fadel | Pharmacology | Best Researcher Award

Dr. Charbel Fadel, University of Pisa, Italy

Dr. Charbel Fadel is a renowned researcher in Veterinary Pharmacology with a PhD from the University of Sassari, Italy. He specializes in pharmacotherapy, quality control, and pharmacokinetics. Currently, Dr. Fadel is a Research Fellow at the University of Pisa, Italy, overseeing pharmacology lab operations and conducting animal studies. With a rich background in veterinary medicine, he has contributed to numerous scientific publications and presented at prestigious international conferences. Dr. Fadel’s work is focused on drug disposition, antimicrobial resistance, and improving veterinary pharmacology practices globally. He holds multiple honors and continues to impact veterinary science.

Publication Profile

Scopus

Education

Dr. Charbel Fadel is a distinguished veterinarian with extensive academic qualifications. He earned his Ph.D. in Veterinary Pharmacology, Pharmacotherapy, and Quality Control from the University of Sassari, Italy, in October 2023. Prior to this, he completed a Master’s degree in Veterinary Medicine, specializing in Small Animals’ Medicine, at L’Université Libanaise, Lebanon, in October 2020. His expertise in veterinary pharmacology and small animal care, combined with a passion for enhancing animal health, defines his professional journey.

Experience

Dr. Charbel Fadel has a rich professional background in veterinary medicine. Currently, he serves as a Research Fellow in Veterinary Pharmacology at the University of Pisa, Italy, where he oversees lab operations, manages pharmacokinetic studies, and collaborates with international teams to refine pharmacotherapy strategies. Before this, he was the Project and Operations Manager at IVet Medical in Beirut, Lebanon. In this role, he provided expert guidance to veterinarians on the use of biomedical machines, biological tests, and surgical instruments, while also managing the procurement and evaluation of medical supplies.

Awards

Dr. Charbel Fadel has earned numerous honors throughout his career. He has been an active reviewer for the Journal of Veterinary Pharmacology and Therapeutics since 2023 and was awarded the “Cultore della Materia” honor by the University of Pisa in January 2024 for his work as a Subject Specialist/Adjunct Lecturer. He received second runner-up for the 2023 JVPT Paper Award from Wiley Publishers, and his article on robenacoxib pharmacokinetics was recognized as the most cited in 2022-2023. Dr. Fadel also contributed to the “Rocinate Program” and completed several veterinary training programs in Russia.

Research Focus

Dr. Charbel Fadel’s research focus lies in veterinary pharmacology, particularly in the comparative pharmacokinetics of various drugs in livestock species like sheep and goats. His studies, including those on metronidazole and omeprazole, aim to enhance the understanding of drug absorption, distribution, metabolism, and excretion in these animals. This research is crucial for optimizing veterinary care and ensuring effective medication dosages in different animal species. Dr. Fadel’s work supports the development of more tailored and efficient treatment protocols for livestock, contributing to both animal health and agricultural practices.

Publication Top Notes

Comparative pharmacokinetic evaluation of metronidazole in sheep and goats

Comparative Pharmacokinetics of Intravenous and Subcutaneous Omeprazole in Sheep and Goats

Ewa Obuchowicz | Pharmacology | Best Researcher Award

Posted on by sciencefather

Ewa Obuchowicz | Pharmacology | Best Researcher Award

Prof. Ewa Obuchowicz, Medical University of Silesia, Poland

Prof. Ewa Obuchowicz is the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia. She earned her M.Sc. in 1979, Ph.D. in 1985, became an Associate Professor in 2001, and a Professor in 2011. Her research focuses on psychotropic drugs, neuropeptides, cytokines, and glioblastoma therapy 🧠🔬. She has authored 89 scientific papers, with over 2,000 citations and an h-index of 20. A recipient of multiple awards 🏆, she is an esteemed member of the Polish Pharmacological Society.

Publication Profile

Scopus

Education

Prof. Ewa Obuchowicz 🎓 is a distinguished expert in pharmacology, with an impressive academic journey spanning decades. She earned her M.Sc. in 1979, followed by a Ph.D. in 1985, and attained full professorship in 2011. As the Head of the Department of Pharmacology at the Faculty of Medical Sciences in Katowice, Medical University of Silesia 🏥, she exemplifies leadership and dedication to advancing medical research. Her extensive contributions and unwavering commitment to the field make her a strong candidate for the Best Researcher Award 🏆, highlighting her impact on academia and scientific progress.

Experience 

Prof. Ewa Obuchowicz 🔬 is a renowned researcher specializing in psychotropic drug mechanisms, neuropeptides, cytokines, and glial cell protein expression. Her work delves into the complex interplay between stress, immunostimulation, and neurotrophic factors 🧠, shedding light on crucial neurological processes. Additionally, she has explored the role of the endocannabinoid system 🌿 and contributed to developing innovative adjuvant therapies for glioblastoma 🎗️. Her groundbreaking research plays a vital role in advancing medical and pharmacological sciences, solidifying her reputation as a distinguished scientist in the field. Her dedication continues to shape the future of neuropharmacology and therapeutic innovation.

Scientific Achievements

Prof. Ewa Obuchowicz 📚 has made a remarkable impact on the scientific community with 89 full-length publications, 71 of which have been cited over 2,000 times. With an h-index of 20 (Scopus) 📊, her research has gained widespread recognition. Notably, five of her papers have been cited over 100 times, highlighting their profound influence. Beyond research articles, she has contributed to authoritative pharmacology handbooks 📖, further solidifying her scholarly excellence. Her outstanding publication record and significant contributions to the field make her a deserving candidate for the award 🏆, reflecting her dedication to advancing pharmacological sciences.

Professional Memberships

Prof. Ewa Obuchowicz 🤝 is an active member of the Polish Pharmacological Society, where she contributes to professional discussions and advancements in pharmacology. Through her engagement with research organizations 🏛️, she fosters collaboration and drives progressive scientific discoveries. Her dedication to the field extends beyond her own research, as she actively participates in shaping the future of pharmacology through knowledge exchange and professional networking. By staying at the forefront of scientific discourse, she continuously enhances the impact of her work, reinforcing her role as a key contributor to the advancement of medical and pharmacological sciences.

Awards

Prof. Ewa Obuchowicz 🏅 has received prestigious recognition for her outstanding contributions to medical and pharmacological research. She has been honored with two Scientific Awards from the Minister of Health and Social Welfare 🏆 and thirteen Scientific Awards from the Rector of the Medical University of Silesia in Katowice 🎖️. These accolades reflect her dedication, innovation, and impact in the field. Her groundbreaking research and scholarly achievements continue to shape the future of pharmacology, further solidifying her candidacy for the Best Researcher Award 🏅 and reinforcing her status as a leading figure in medical science.

Research Focus

Professor Ewa Obuchowicz is a distinguished neuroscientist specializing in psychopharmacology 🧠💊, with a research focus on depression, stress, and the endocannabinoid system. Her work explores the mechanisms of antidepressants, particularly escitalopram, and their effects on neurotransmission, gene expression, and behavioral responses. She has contributed significantly to preclinical models of stress and mood disorders, investigating the role of neuropeptides, oxytocin, and the hypothalamus-pituitary-gonadal (HPG) axis 🔬📊. Additionally, her research extends to neuro-oncology, examining glioblastoma treatments. Through her studies, she aims to advance mental health therapeutics and improve understanding of stress-induced disorders.

Publication Top Notes

Escitalopram reverses anxiety-like and despair behavior and affects endocannabinoid-related genes expression in the brain of adolescent male rats subjected to early life stress

Acute Stress Affects the Relaxin/Insulin-Like Family Peptide Receptor 3 mRNA Expression in Brain of Pubertal Male Wistar Rats

How depression and antidepressant drugs affect endocannabinoid system?—review of clinical and preclinical studies

A Dot-Blot Screening for Identifying the Temozolomide-Regulated Proteins as Potential Targets for Glioma Multi-OMICS Studies

Escitalopram alters the hypothalamic OX system but does not affect its up-regulation induced by early-life stress in adult rats.

Neuropeptides as regulators of the hypothalamus-pituitary-gonadal (HPG) axis activity and their putative roles in stress-induced fertility disorders

Glucose Influences the Response of Glioblastoma Cells to Temozolomide and Dexamethasone

May application of oxytocin be relevant in the therapy of perinatal mental disorders?

Dr. Rahul Reddy|Pharmacology|Excellence in Research

Posted on by sciencefather

Dr.RahulReddy|Pharmacology|Excellence in Research

Dr. Rahul Reddy at Lautoka Hospital ,Fiji

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Rahul Krishna Reddy, a passionate medical professional, laid the foundation of his academic journey at Lautoka Andhra Sangam Primary School, where he studied from 2000 to 2008. He then progressed to Natabua High School (2009–2013), excelling academically and developing a keen interest in the medical sciences. His educational journey gained international momentum when he pursued a Chinese language program (HSK Level 4) at Shandong University in 2013–2014. This preparatory phase was instrumental in equipping him with linguistic skills for his future studies in China.

Rahul enrolled at Dalian Medical University (2014–2019), where he earned his MBBS degree. His time at Dalian was marked by rigorous academic training and multiple internships, including at the First Affiliated Hospital of Dalian Medical University. This exposure to advanced medical systems honed his clinical skills and solidified his career in surgery and medicine.

Professional Endeavors 🩺

Rahul’s professional journey is a testament to his dedication and commitment to the healthcare field. His initial post-MBBS years were spent at renowned institutions, including the Colonial War Memorial Hospital and Lautoka Hospital, where he completed intensive internship programs (2019–2021). These internships provided him with hands-on experience in diverse medical and surgical disciplines.

From 2021 to 2022, he played a crucial role in Fiji’s fight against COVID-19 as part of the Nadroga/Navosa COVID Team, showcasing his adaptability and resilience in public health crises. Later, as a Medical Officer at Vatukarasa Health Center (2022–2023), Rahul delivered primary care services, demonstrating his ability to cater to the diverse medical needs of his community. Currently, he serves as a Surgical Registrar at Lautoka Hospital, focusing on complex surgical cases and contributing significantly to patient outcomes.

Contributions and Research Focus 🔬

Rahul has made significant strides in clinical research, focusing on improving healthcare outcomes in Fiji. His studies have explored critical areas such as burn injuries, appendicitis, and innovative surgical techniques. Notable publications include:

  • Burns Injury Characteristics and Outcomes at Lautoka Hospital, highlighting critical insights into managing burn patients in resource-limited settings.
  • Research on acute appendicitis outcomes, offering data-driven recommendations for improving surgical care in Fiji.
  • Pioneering work on laparoscopic radical prostatectomy, reflecting his interest in minimally invasive surgery.
  • Contributions to the understanding of rare cases like primary epithelioid hemangioendothelioma and seminal vesicle cystadenoma through internationally recognized publications.

Rahul’s commitment to research and evidence-based practice demonstrates his dedication to advancing medical science in the Pacific region.

Accolades and Recognition 🏆

Rahul’s work has been recognized both nationally and internationally. In 2024, he won the Outstanding Young Investigator Award at the Fiji Medical Association Research Conference. His impactful presentations at conferences, including the Diabetic Foot Symposium and the Pacific Islands Health Research Symposium, have established him as a thought leader in surgical and public health topics.

Rahul has also actively participated in workshops, such as the EMSB and Pain Management sessions, further enhancing his clinical expertise. His continued professional development reflects his commitment to lifelong learning.

Impact and Influence 🌏

Rahul’s influence extends beyond the operating room. As a healthcare provider in Fiji, he has been instrumental in improving patient care and mentoring junior medical staff. His research contributions address key regional healthcare challenges, ensuring evidence-based practices are integrated into daily medical routines.

During the COVID-19 pandemic, his involvement in the Nadroga/Navosa COVID Team was pivotal in managing the outbreak, reflecting his leadership skills and community dedication.

Legacy and Future Contributions 🚀

Rahul Krishna Reddy is poised to leave a lasting legacy in the medical field. His combination of clinical expertise, research acumen, and community service positions him as a trailblazer in Fijian healthcare. Looking ahead, Rahul envisions expanding his contributions to global medical research, particularly in surgical innovation and healthcare systems in resource-limited settings.

His unwavering dedication to improving healthcare outcomes and fostering medical education ensures his enduring impact. As he continues to grow professionally, Rahul exemplifies the values of compassion, innovation, and excellence in medicine.

Conclusion 🌟

From his early academic achievements to his current role as a Surgical Registrar, Rahul Krishna Reddy’s journey reflects an unwavering commitment to healthcare. His research and clinical endeavors are paving the way for improved medical practices in Fiji and beyond. Rahul’s accomplishments and aspirations set a high standard for the next generation of medical professionals, cementing his position as a leader in the field.

🎓Publication 

Laparoscopic excision of seminal vesicle cystadenoma

  • Authors   : Qi Zhen Tang, Zhong Lin, Rahul Krishna Reddy, Zhi Wei Zhang
  • Journal    : Urology Case Reports
  • Year         :2019

Burns injury characteristics and outcomes at lautoka hospital, fiji

      • Authors   : Rahul Krishna Reddy, Arun Murari, Akhtar Ali, Ronal Kumar, Livai Lutunaika, Abhay Choudhari, Swastika Devi, Famiza Kulsum
      • Journal    : Burns Open
      • Year         :2024

Characteristics and Outcomes of Acute Appendicitis in Lautoka Aspen Hospital, Fiji: An Observational Retrospective Study

  • Authors   : Rahul Krishna Reddy, M Arun, K Ronal, Akhtar Ali, Livai Lutunaika, Y Devi Chandra
  • Journal    : World J Surg Surgical Res
  • Year         :2024

Primary Epithelioid Hemangioendothelioma of the Kidney Pelvis

  • Authors   :Rahul Reddy
  • Journal     : American Journal of Surgery and Clinical Case Reports
  • Year         :2020                                                                                                                                                                                                                                                 

Prof Dr. Elaine Leung|Pharmacology | Best Researcher Award

Posted on by sciencefather

Prof Dr. Elaine Leung |Pharmacology|Best Researcher Award|

Prof Dr. Elaine Leung at Department of Biomedical Science, Faculty of Health Science, Macau

PROFILE  

scopus

 

Early Academic Pursuits 🎓

Elaine Lai-Han Leung embarked on her academic journey with a strong foundation in biological sciences, obtaining her BSc in Biology and Biochemistry from The Chinese University of Hong Kong in 2001. Her deep interest in biomedical sciences led her to pursue further studies, earning an MPhil in Biochemistry in 2003, followed by a PhD in Physiology in 2006 from the same institution. Her early academic pursuits laid the groundwork for a career marked by significant contributions to biomedical research, particularly in the fields of cancer biology and traditional Chinese medicine.

Professional Endeavors 🧬

Professor Leung’s professional career has been centered at the University of Macau, where she is a prominent figure in the Department of Biomedical Science, Faculty of Health Science. Over the years, she has established herself as a leading researcher, focusing on the intersection of modern biomedical sciences and traditional Chinese medicine. Her work has involved both academic research and collaborations with industry, where she has taken on numerous consultancy projects, contributing to the development of new therapies and drug discoveries.

Contributions and Research Focus 🔬

Professor Leung’s research is primarily focused on cancer biology, with an emphasis on non-small cell lung cancer (NSCLC). She has been the principal investigator (PI) or co-investigator (Co-I) on numerous research projects, many of which are aimed at understanding the mechanisms of drug resistance and the development of novel therapeutic strategies. Her ongoing research includes studies on KRAS resistance mechanisms, the role of gut microbiota in cancer immunomodulation, and the use of traditional Chinese medicine in treating various forms of cancer.

Some of her key projects include:

  • The relationship between KRAS resistance mechanisms and the immune microenvironment: An ongoing project at the University of Macau aimed at uncovering how KRAS mutations affect immune responses in cancer.
  • High-dimensional single-cell analysis of Sotorasib resistance clinical samples: This research seeks to identify new small molecule inhibitors for treating NSCLC.
  • Investigation of the anti-tumor effect of microbial valeric acid in NSCLC: Completed in 2023, this study explored how microbial byproducts can influence tumor immunity.

Accolades and Recognition 🏆

Professor Leung’s contributions to biomedical science have not gone unnoticed. She has been recognized with numerous awards and honors throughout her career, reflecting her standing in the scientific community. Her work has been cited extensively in leading scientific journals, with her citation index reflecting her influence in the fields of cancer biology and traditional Chinese medicine. Her collaboration with Nobel Laureate Erwin Neher on drug research further underscores her prominence in the field.

Impact and Influence 🌍

The impact of Professor Leung’s work extends beyond academia. Her research has significant implications for the development of new cancer therapies, particularly in the context of drug resistance. By bridging the gap between traditional Chinese medicine and modern biomedical research, she has opened new avenues for treatment that could benefit patients worldwide. Her work on gut microbiota and its role in cancer treatment, for instance, is pioneering in its approach and has the potential to revolutionize how cancer is treated.

Legacy and Future Contributions 🌟

As Professor Leung continues her work at the University of Macau, her legacy is already taking shape. She is helping to mentor the next generation of scientists while pushing the boundaries of what is possible in cancer research. Her ongoing projects, including those funded by significant grants, are expected to yield new insights into cancer biology and treatment. Looking ahead, her contributions will likely continue to influence the field of biomedical sciences, particularly in how traditional Chinese medicine is integrated into modern therapeutic strategies.

Research and Innovations 🧪

Completed/Ongoing Research Projects 📊

Professor Leung has completed numerous research projects, with many others ongoing. Her portfolio includes more than a dozen major projects, ranging from small-scale studies to large, collaborative efforts with industry partners. These projects have attracted significant funding, including:

  • Macao Science and Technology Development Fund (2021/2024): Investigating the combinational treatment effects of ginseng polysaccharides with immunotherapy in lung cancer, with a budget of USD 230,769.
  • Zhuhai UM Science and Technology Institute joint lab projects: Ongoing studies on drug resistance and immune microenvironment interactions in cancer, funded at approximately USD 641,000.

Citation Index 📚

Professor Leung’s work is highly regarded in the scientific community, as reflected by her citation index in databases such as Scopus and the Science Citation Index (SCI). Her research articles have been cited extensively, demonstrating the impact and relevance of her work in advancing biomedical science.

Consultancy/Industry Projects 🤝

Beyond academia, Professor Leung has engaged in several industry-sponsored projects, often serving as a consultant. These projects have allowed her to apply her research in practical settings, contributing to the development of new drugs and therapeutic strategies. Notably, she has collaborated with leading pharmaceutical companies like Janssen Pharmaceuticals, where her work on immunophenotyping in lung cancer patients has been highly influential.

Conclusion 🎯

Professor Elaine Lai-Han Leung’s career is a testament to the power of interdisciplinary research and collaboration. Her contributions to cancer biology, her innovative use of traditional Chinese medicine, and her commitment to bridging the gap between research and industry have made her a pivotal figure in her field. As she continues to explore new frontiers in biomedical science, her legacy will undoubtedly be one of lasting impact, shaping the future of cancer treatment and beyond.

🎓Publication 

Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer

  • Authors   :Zhang, Y.-Z., Lai, H.-L., Huang, C., … Wu, Q.-B., Leung, E.L.-H.
  • Journal    :Phytomedicine
  • Year         :2024

Genome engineering of the human gut microbiome

MMP14high macrophages orchestrate progressive pulmonary fibrosis in SR-Ag-induced hypersensitivity pneumonitis

  • Authors   :Peng, D., Li, J., Li, Y., … Yang, P., Li, G.
  • Journal    :Pharmacological Research.
  • Year         :2024

Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis

 

Prof. Mohamed Abdelzaher|Pharmacology | Best Researcher Award

Posted on by sciencefather

Prof. Mohamed Abdelzaher, Pharmacology,Best Researcher Award

Prof. Mohamed Abdelzaher, at Environmental Science and Industrial Development Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University,Egypt

PROFILE

scopus

Early Academic Pursuits 🎓

Mohamed Abuelseoud Abdelzaher embarked on his academic journey at Minia University, where he pursued a Bachelor of Science degree at the Faculty of Science. His passion for environmental science led him to further his studies, culminating in an MSc in Environmental Chemistry from the same institution. His master’s thesis focused on the physico-chemical properties of sewage sludge ash blended cement pastes, a topic that underscored his growing interest in sustainable construction materials. His academic pursuits did not stop there, as he later achieved a Ph.D. in Environmental Science and Industrial Development from the Faculty of Postgraduate Studies for Advanced Sciences at Beni-Suef University in 2019. His doctoral research delved into enhancing the physico-mechanical properties of white cement through the application of nanoparticles, highlighting his commitment to advancing materials science and its environmental implications.

Professional Endeavors 🏢

Dr. Abdelzaher’s professional career began in the industrial sector, where he worked as a Quality Control and Labs Manager at Italcementi Group, Helwan Cement Co., from 2005 to 2017. This role allowed him to gain substantial experience in quality assurance and environmental management within the cement industry. His work in this capacity was instrumental in ensuring that the company adhered to stringent environmental and quality standards, contributing to the sustainability of its operations.

In 2017, Dr. Abdelzaher transitioned into academia, taking on the role of Assistant Professor of Environmental Science and Industrial Development at Beni-Suef University’s Faculty of Postgraduate Studies for Advanced Sciences. In this role, he has been actively involved in teaching, research, and mentorship, guiding the next generation of environmental scientists and engineers. His professional journey reflects a seamless blend of industry experience and academic expertise, making him a respected figure in both fields.

Contributions and Research Focus 🔬

Dr. Abdelzaher’s research is primarily centered on the application of nanomaterials in construction materials and environmental science, with a particular emphasis on waste management. His work on enhancing the properties of white cement using nanoparticles is a testament to his innovative approach to solving environmental and industrial challenges. By integrating cutting-edge nanotechnology into traditional construction materials, he has contributed to the development of more durable and sustainable building solutions.

In addition to his research in construction materials, Dr. Abdelzaher has also made significant contributions to environmental science, particularly in the area of waste management. His work explores how waste materials can be repurposed and utilized in environmentally friendly ways, thereby reducing their impact on the environment and contributing to a circular economy.

Accolades and Recognition 🏅

Throughout his career, Dr. Abdelzaher has received numerous accolades and certifications that attest to his expertise and leadership in his field. He is a certified environmental specialist, having received recognition from the Egyptian Ministry of Environment. He also holds an MBA from Ain Shams University, which complements his scientific expertise with strong business acumen.

Dr. Abdelzaher’s leadership skills have been recognized on an international level, as evidenced by his fellowship from the Science Leadership Program in Africa. This fellowship highlights his role as a thought leader in environmental science, particularly in the context of developing nations. Additionally, he has been awarded fellowships for curriculum development and environmental management, further underscoring his contributions to academia and industry alike.

Impact and Influence 🌍

Dr. Abdelzaher’s work has had a profound impact on both the academic community and the industrial sector. His research on nanomaterials and waste management has influenced the development of more sustainable construction practices, contributing to the global push towards greener building solutions. His teachings and mentorship at Beni-Suef University have inspired countless students to pursue careers in environmental science, ensuring that his influence will be felt for generations to come.

Moreover, his involvement in various professional organizations and his role as a reviewer for environmental journals published by Elsevier demonstrate his commitment to advancing the field of environmental science. Through these roles, he has helped shape the direction of research and development in his field, ensuring that it continues to address the most pressing environmental challenges of our time.

Legacy and Future Contributions 🚀

As Dr. Abdelzaher continues his career, his legacy is one of innovation, leadership, and dedication to sustainability. His work in nanotechnology and waste management has laid the groundwork for future advancements in these fields, and his influence as an educator ensures that his knowledge and expertise will be passed on to the next generation of environmental scientists.

🎓Publication 

Effective impact of nano-plastic-waste incorporated with nanotitina on the physical, mechanical and microstructural properties of white cement pastes composites for progressing towards sustainability

  • Authors   :Abdelzaher, M.A., Farghali, A.A., Hamouda, A.S.
  • Journal    :Scientific Reports
  • Year         :2024

Production, characterization and performance of green geopolymer modified with industrial by-products

    • Authors :Abbas, R., Abdelzaher, M.A., Shehata, N., Tantawy, M.A.
    • Journal   :Scientific Report
    • Year       : 2024

Effect of ginger, chamomile, and green tea extracts on prostate cancer cells

Bacterial biodegradation of oil-contaminated soil for pollutant abatement contributing to achieve sustainable development goals: A comprehensive review

  • Authors  :Aziz, Z.S., Jazza, S.H., Dageem, H.N., … Balboul, B.A., Abdelzaher, M.A.
  • Journal   :Results in Engineering
  • Year        :   2024

Experimental and Theoretical Study of Water Amount on the Rheological Features of Marble Sludge Grout

Dr. Samer Younes| Pharmacology| Best Researcher Award-1225

Posted on by sciencefather

Dr. Samer Younes,Pharmacology ,Best Researcher Award

Dr. Samer Younes, at Tartous University, Syria

 Profile

Goole scholar

    

🎓Early Academic Pursuits :

Samer Younes began his academic journey with a strong focus on pharmaceutical sciences. His passion for the field was evident early on as he pursued a Bachelor’s degree in Pharmacy from the Faculty of Pharmacy at Tartous University, Syria. His dedication to his studies was unwavering, and he successfully completed his degree on January 31, 2024. This foundational education equipped him with extensive knowledge in clinical pharmacology and pharmaceutical services, setting the stage for his professional and academic endeavors.

💼Professional Endeavors :

Upon completing his degree, Samer Younes embarked on a professional career that quickly showcased his capabilities and commitment to the field. With two years of experience in pharmaceutical services, he demonstrated a compassionate and systematic approach to his work. His extensive background in clinical pharmacology and strong clinical and technical knowledge enabled him to deliver community health education programs effectively. Samer’s professional journey has been marked by a relentless pursuit of excellence and a desire to contribute significantly to the field of pharmacy.

🧪Contributions and Research Focus :

Samer Younes has made notable contributions to pharmaceutical research and innovation. His research endeavors have been diverse and impactful, with a focus on nutrition, nutrients, and pharmacology. He has completed or is currently engaged in 19 research projects, showcasing his dedication to advancing knowledge in his field. His work has been recognized and cited in relevant academic databases, reflecting the significance of his contributions to the scientific community. Samer’s research is characterized by its rigor and relevance, addressing critical issues in pharmacology and drug discovery.

🏆Accolades and Recognition :

Throughout his academic and professional journey, Samer Younes has received recognition for his outstanding contributions. His research has been published in reputable journals, and he has been involved in 19 consultancy or industry-sponsored projects. These achievements underscore his expertise and the high regard in which he is held within the pharmaceutical community. Although specific awards and honors have not been detailed, his professional and academic accomplishments speak volumes about his impact and influence in the field.

🌍Impact and Influence :

Samer Younes’s work has had a significant impact on both his immediate community and the broader field of pharmaceutical sciences. His involvement in community health education programs has helped raise awareness and improve public health outcomes. Additionally, his research contributions have advanced the understanding of various aspects of pharmacology, influencing both academic and practical applications. His commitment to sharing knowledge and improving healthcare practices highlights his role as a leader and innovator in the field.

🌟Legacy and Future Contributions :

Looking ahead, Samer Younes is poised to make even greater contributions to pharmaceutical sciences. His pursuit of full-funded scholarships for continuing his master’s degree studies indicates a commitment to furthering his education and research capabilities. With his solid academic background, professional experience, and ongoing research projects, Samer is well-positioned to leave a lasting legacy in the field. His future contributions are expected to drive innovation, enhance pharmaceutical practices, and inspire the next generation of pharmacists and researchers.

🎓Publication 

The efficacy of a 24-hour preoperative pause for SGLT2-inhibitors in type II diabetes patients undergoing bariatric surgery to mitigate euglycemic diabetic ketoacidosis

  • Authors   :Samer Younes
  • Journal    :Diabetes Epidemiology and Management
  • Year         : 2024

The role of nutrition on the treatment of Covid 19

    • Authors :Samer Younes
    • Journal   :Human Nutrition & Metabolism
    • Year       : 2024

The role of micronutrients on the treatment of diabetes

  • Authors  :Samer Younes
  • Journal    :Human Nutrition & Metabolism
  • Year         :  2024

The impact of micronutrients on the sense of taste

  • Authors  :Samer Younes
  • Journal   :Human Nutrition & Metabolism
  • Year        :   2023

A Comprehensive Examination of the Nutritional Sufficiency of Vegan Recipes Widely Available in the Market

  • Authors  :Samer Younes
  • Journal   :J. Nutrition and Food Processing
  • Year        :   2024